Literature DB >> 7252407

Mast cell-mediated tumor-cell cytotoxicity. Role of the peroxidase system.

W R Henderson, E Y Chi, E C Jong, S J Klebanoff.   

Abstract

Mast cells, when supplemented with H2O2 and iodide, are cytotoxic to mammalian tumor cells as determined by 51Cr release, and transmission and scanning electron microscopy. H2O2 at the concentration employed (10(-4) M) initiates mast cell degranulation, and mast cell granules (MCG), which contain a small amount of endogenous peroxidase activity, are toxic to tumor cells when combined with H2O2 and iodide. This toxicity is greatly increased by binding eosinophil peroxidase (EPO) to the MCG surface. Each component of the mast cell, MCG, or MCG-EPO system was required and toxicity was inhibited by the addition of the hemeprotein inhibitors azide or aminotriazole, which is compatible with a requirement for peroxidase in the cytotoxic reaction. A sequence of reactions is proposed in which mast cells, stimulated to release their granules by H2O2 generated by adjacent phagocytes, react with H2O2 and a halide to damage tumor cells. EPO release from eosinophils may contribute to this sequence of reactions, both by stimulation of H2O2-induced mast cell secretion and by combination with MCG to form a complex with augmented tumoricidal activity. These rections may play a role in the host defense against neoplasms.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7252407      PMCID: PMC2186115          DOI: 10.1084/jem.153.3.520

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  17 in total

1.  Functional characteristics of mast cells associated with rat mammary tumors induced by 7,12-dimethylbenz(a)anthracene.

Authors:  J W Combs; D M Purnell
Journal:  J Natl Cancer Inst       Date:  1973-04       Impact factor: 13.506

2.  Metabolic and bactericidal activities of human eosinophils.

Authors:  R L Baehner; R B Johnston
Journal:  Br J Haematol       Date:  1971-03       Impact factor: 6.998

3.  Mast cells and cancer of the cervix.

Authors:  R M Graham; J B Graham
Journal:  Surg Gynecol Obstet       Date:  1966-07

4.  Peroxidase-H2O2-halide system: Cytotoxic effect on mammalian tumor cells.

Authors:  R A Clark; S J Klebanoff; A B Einstein; A Fefer
Journal:  Blood       Date:  1975-02       Impact factor: 22.113

5.  Functional studies on human peritoneal eosinophils.

Authors:  S J Klebanoff; D T Durack; H Rosen; R A Clark
Journal:  Infect Immun       Date:  1977-07       Impact factor: 3.441

6.  Numbers of mast cells in the axillary lymph nodes of breast cancer patients.

Authors:  H M Bowers; R C Mahapatro; J W Kennedy
Journal:  Cancer       Date:  1979-02       Impact factor: 6.860

7.  Ultrastructural observations on the in vitro interaction between rat eosinophils and some parasitic helminths (Schistosoma mansoni, Trichinella spiralis and Nippostrongylus brasiliensis).

Authors:  D J McLaren; C D Mackenzie; F J Ramalho-Pinto
Journal:  Clin Exp Immunol       Date:  1977-10       Impact factor: 4.330

8.  The entry of granule-associated peroxidase into the phagocytic vacuoles of eosinophils.

Authors:  R S Cotran; M Litt
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

9.  Peroxidase-mediated mammalian cell cytotoxicity.

Authors:  P J Edelson; Z A Cohn
Journal:  J Exp Med       Date:  1973-07-01       Impact factor: 14.307

10.  Immunologic rejection of diethylnitrosamine-induced hepatomas in strain 2 guinea pigs: participation of basophilic leukocytes and macrophage aggregates.

Authors:  H F Dvorak; A M Dvorak; W H Churchill
Journal:  J Exp Med       Date:  1973-03-01       Impact factor: 14.307

View more
  33 in total

Review 1.  Tryptase and chymase, markers of distinct types of human mast cells.

Authors:  S S Craig; L B Schwartz
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

Review 2.  Mast cell polymorphisms. Present concepts, future directions.

Authors:  D Befus; H Fujimaki; T D Lee; M Swieter
Journal:  Dig Dis Sci       Date:  1988-03       Impact factor: 3.199

3.  Combinatorial Effect of Abiraterone Acetate and NVP-BEZ235 on Prostate Tumor Progression in Rats.

Authors:  Bianca Facchim Gonçalves; Silvana Gisele Pegorin de Campos; Wagner José Fávaro; Joyce Zalotti Brandt; Cristiane Figueiredo Pinho; Luis Antônio Justulin; Sebastião Roberto Taboga; Wellerson Rodrigo Scarano
Journal:  Horm Cancer       Date:  2018-01-23       Impact factor: 3.869

4.  Cell-mediated cytotoxicity by natural killer and killer cells, lipid peroxidation and glutathione.

Authors:  M Younes; G Craig; N H Stacey
Journal:  Experientia       Date:  1986-12-01

Review 5.  Tumor cells do not arise frequently.

Authors:  W Den Otter
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

6.  Presence of tumour necrosis factor or a related factor in human basophil/mast cells.

Authors:  M Steffen; M Abboud; G K Potter; Y P Yung; M A Moore
Journal:  Immunology       Date:  1989-03       Impact factor: 7.397

7.  Prognostic significance of cell infiltrations of immunosurveillance in colorectal cancer.

Authors:  Shi-Yun Tan; Yan Fan; He-Sheng Luo; Zhi-Xiang Shen; Yi Guo; Liang-Jia Zhao
Journal:  World J Gastroenterol       Date:  2005-02-28       Impact factor: 5.742

8.  Vesicular uptake of eosinophil peroxidase by guinea pig basophils and by cloned mouse mast cells and granule-containing lymphoid cells.

Authors:  A M Dvorak; S J Klebanoff; W R Henderson; R A Monahan; K Pyne; S J Galli
Journal:  Am J Pathol       Date:  1985-03       Impact factor: 4.307

9.  Activation and release of enzymes and major basic protein from guinea pig eosinophil granulocytes induced by different inflammatory stimuli and other substances. A histochemical, biochemical, and electron microscopic study.

Authors:  H Popper; G Knipping; B M Czarnetzki; R Steiner; G Helleis; H Auer
Journal:  Inflammation       Date:  1989-04       Impact factor: 4.092

10.  Sequential mast cell infiltration and degranulation during experimental carcinogenesis.

Authors:  E A Flynn; J L Schwartz; G Shklar
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.